WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ORCHESTRATING THE IMMUNE SYSTEM wurde als Wortmarke am 24.01.2023 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1716349 |
| Länder | 
|
| Basismarke |
Nr. 97518230,
25. Juli 2022
|
| Anmeldedatum | 24. Januar 2023 |
| Ablaufdatum | 24. Januar 2033 |
Markeninhaber
410 W Harrison Street, Suite 150
Seattle WA 98119
US
Seattle WA 98119
US
Markenvertreter
801 California Street,
Silicon Valley Center
US
Waren und Dienstleistungen
05
Pharmaceutical products and preparations for the prevention
and treatment of diseases and disorders, namely, autoimmune
diseases and disorders, inflammatory diseases and disorders,
infectious diseases and disorders, cancer, gastrointestinal
diseases and disorders, and other related diseases and
disorders; biological products and preparations, for the
prevention and treatment of diseases and disorders, namely,
autoimmune diseases and disorders, inflammatory diseases and
disorders, gastrointestinal diseases and disorders,
infectious diseases and disorders, cancer and other related
diseases and disorders; cell therapy products and
preparations for the prevention and treatment of diseases
and disorders, namely, autoimmune diseases and disorders,
inflammatory diseases and disorders, gastrointestinal
diseases and disorders, infectious diseases and disorders,
cancer and other related diseases and disorders; therapeutic
products and preparations, for the prevention and treatment
of diseases and disorders, namely, autoimmune diseases and
disorders, inflammatory diseases and disorders,
gastrointestinal diseases and disorders, infectious diseases
and disorders, cancer and other related diseases and
disorders; pharmaceutical, biological, cell therapy,
therapeutic and medicinal products and preparations for use
in combination with other therapies for the treatment and
prevention diseases and disorders, namely, autoimmune
diseases and disorders, inflammatory diseases and disorders,
gastrointestinal diseases and disorders, infectious diseases
and disorders, cancer and other related diseases and
disorders; diagnostic biomarker reagents for use in
diagnosing, preventing, and treating diseases and disorders,
namely, autoimmune diseases and disorders, inflammatory
diseases and disorders, gastrointestinal diseases and
disorders, infectious diseases, cancer and other related
diseases and disorders; diagnostic agents, preparations, and
substances for use in diagnosing, preventing, and treating
diseases and disorders, namely, autoimmune diseases and
disorders, inflammatory diseases and disorders, infectious
diseases and disorders, cancer, gastrointestinal diseases
and disorders, and other related diseases and disorders
42
Pharmaceutical research and development in the field of
autoimmune diseases and disorders, inflammatory diseases and
disorders, gastrointestinal diseases and disorders,
infectious diseases and disorders, cancer and other related
diseases and disorders; medical, pharmaceutical, therapeutic
and scientific research in the field of autoimmune diseases
and disorders, inflammatory diseases and disorders,
gastrointestinal diseases and disorders, infectious diseases
and disorders, cancer and other related diseases and
disorders; medical, pharmaceutical, therapeutic and
scientific research in the field of biomarkers for use in
diagnosing, preventing, and treating diseases and disorders,
namely, autoimmune diseases and disorders, inflammatory
diseases and disorders, gastrointestinal diseases and
disorders, infectious diseases and disorders, cancer and
other related diseases and disorders; clinical research and
testing in the field of autoimmune diseases and disorders,
inflammatory diseases and disorders, gastrointestinal
diseases and disorders, infectious diseases and disorders,
cancer and other related diseases and disorders; clinical
research and testing in the field of biomarkers for use in
diagnosing, preventing, and treating diseases and disorders,
namely, autoimmune diseases and disorders, inflammatory
diseases and disorders, infectious diseases and disorders,
cancer and other related diseases and disorders; conducting
clinical trials in the field of autoimmune diseases and
disorders, inflammatory diseases and disorders, infectious
diseases and disorders, cancer gastrointestinal diseases and
disorders, and other related diseases and disorders;
providing medical, clinical and scientific research
information in the field of pharmaceuticals and clinical
trials for use in diagnosing, preventing, and treating
diseases and disorders, namely, autoimmune diseases and
disorders, inflammatory diseases and disorders,
gastrointestinal diseases and disorders, infectious diseases
and disorders, cancer and other related diseases and
disorders
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 26. Juli 2023 | 2023/30 Gaz | CN | Ablehnung |
| 23. Mai 2023 | 2023/21 Gaz | Löschung | |
| 31. März 2023 | 2023/15 Gaz | EM | Ablehnung |
| 24. Januar 2023 | 2023/7 Gaz | US | Eintragung |
ID: 141716349